The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

The Centers for Disease Control and Prevention have issued a new recommendation to protect babies against RSV. According to the updated guidelines, infants under the age of 8 months should receive a ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

Influenza and other respiratory viruses are starting to circulate but so far remain lower than this time last year, according to the Centers for Disease Control and Prevention. As of Oct. 7, CDC's ...

Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.

Public health officials are reminding people to take precautions as flu and RSV cases rise. New York saw an 80% spike in flu ...